lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Multimorbidity has become “a Thing”

18 October 2017 - Dr Genevieve Yates

Why has multimorbidity become a “thing”

– a generally known phenomenon?  This is probably because it is being referenced more and more in policy (and funding related) documents and this is because multimorbidity is identified as a cause of increased health care costs.

A few decades ago, chronic diseases began to assume importance as they became relatively more common when compared to acute illnesses and as infectious diseases have become more treatable.  Co-morbidities then began to be mentioned in specialist clinics where it was noted that, for instance, patients with COPD might also have cardiac or peripheral vascular disease – and that these co-morbidities and their treatments might impact on the disease under care.

Specialist vs generalist

This was a rather specialist view. In the Geriatric literature there had always been a focus on multiple medications (Polypharmacy) and interest began to increase in the complexity of management of (often older) patients with multiple conditions (multimorbidity).  Over the last three decades the number of articles exploring multimorbidity has increased exponentially.  There are various issues regarding definition (how many conditions, how specific, how chronic).  In Australia it is likely that some measure of multimorbidity will be included in stratifying patients for funding in Health Care Homes.

In General Practice

In patient-centred General Practice it is the patient with multiple conditions who is recognised as the reality and seen as the focus of concern (rather than the disease).  This is particularly relevant in a context of increasing sub-specialisation. Managing the associated interactions and integrating available guidelines are challenges.  A very useful patient-centred concept that has emerged for such complex patients is that of Minimally Disruptive Medicine which recognises that health professionals often increase a patient’s burden and make “compliance” problematic.  Managing all of this appropriately is beneficial for the patient and the health system, in both the long and short term and is a relevant goal in the GP context.

Some useful references

The American Geriatric Society has produced a handy Pocketcard summary of their guidelines.

In the UK,  Multimorbidity guidelines have been produced

Minimally Disruptive Medicine: Is healthcare careful? Is it kind?

MedEdPurls has three posts on Teaching Multimorbidity:

http://mededpurls.com/blog/index.php/2016/10/31/teaching-multimorbidity-part-one/

http://mededpurls.com/blog/index.php/2016/11/05/teaching-multimorbidity-part-two/

http://mededpurls.com/blog/index.php/2016/11/13/teaching-multimorbidity-part-three/

Dr Genevieve Yates
Dr Genevieve Yates

Genevieve is an educator, a GP and a writer in regional Victoria.

Read more
Related Categories
Get Medcast Plus

Become a member and get unlimited access to 100s of hours of premium education.

Learn more
Related News
Recognising and responding to suicide risk in Australian veterans: a guide for GPs

Dr Catherine Eltringham

Brand icon

This article equips GPs with practical strategies to recognise and assess suicide risk in Australian veterans. It outlines tools to support your consultation and assessment, and highlights referral pathways such as Open Arms – Veterans and Families Counselling and DVA services to support early intervention and save lives in general practice.

10 mins READ
Gas trapping & breath stacking - What is your asthmatic patient telling you?

Susan Helmrich

This article explores the risks and management of dynamic hyperinflation in mechanically ventilated patients with status asthmaticus. It outlines causes such as airway obstruction and bronchospasm, and provides strategies for adjusting ventilation settings to minimise gas trapping, support cardiac function, and reduce complications like pneumothorax and systemic hypotension.

5 mins READ
Atrial fibrillation stroke prevention - clinical fact sheet and MCQ

Quality Use of Medicines Alliance

Brand icon

This is the second FastTrack on atrial fibrillation (AF). Part 1 described the diagnosis, initial assessment of AF, and indications for urgent review. This FastTrack describes the approach to setting a management strategy using risk calculators, how to assess and reduce risk factors, and long term monitoring of patients with AF.

10 mins READ